CELL LINE CELL TYPE SPECIES TISSUE MEDIUM
3T6 fibroblast mouse embryo DMEM, 10% FBSA549 epithelial human lung carcinoma F-12K, 10% FBSA9 fibroblast mouse connective tissue DMEM, 10% FBSAtT-20 epithelial mouse pituitary tumor F-10, 15% horse serum and 2.5% FBSBALB/3T3 fibroblast mouse embryo DMEM, 10% FBSBHK-21 fibroblast hamster kidney GMEM, 10% FBS or MEM, 10% FBS and NEAABHL-100 epitheliall human breast McCoy'5A, 10% FBSBT fibroblast bovine turbinate cells MEM, 10% FBS and NEAACaco-2 epithelial human colon adeno carcinoma MEM, 20% FBS and NEAAChang epithelial human liver BME, 10% calf serumCHO-K1 epithelial hamster ovary F-12, 10% FBSClone 9 epithelial rat liver F-12K, 10% FBSClone M-3 epithelial mouse melanoma F-10, 15% horse serum and 2.5% FBSCOS-1 fibroblast monkey kidney DMEM, 10% FBSCOS-3 fibroblast monkey kidney DMEM, 10% FBSCOS-7 fibroblast monkey kidney DMEM, 10% FBSCRFK epithelial cat kidney MEM, 10% FBS and NEAACV-1 fibroblast monkey kidney MEM, 10% FBSD-17 epithelial dog osteosarcoma MEM, 10% FBS and NEAADaudi lymphoblast human blood from a lymphoma patient RPMI-1640, 10% FBSGH1 epithelial rat pituitary tumor F-10, 15% horse serum and 2.5% FBSGH3 epithelial rat pituitary tumor F-10, 15% horse serum and 2.5% FBSH9 lymphoblast human T-cell lymphoma RPMI-1640, 20% FBSHaK epithelial hamster kidney BME, 10% calf serumHCT-15 epithelial human colorectal adenocarcinoma RPMI-1640, 10% FBSHeLa epithelial human cervix carcinoma MEM, 10% FBS and NEAA (in suspension, S-MEM)HEp-2 epithelial human larynx carcinoma MEM, 10% FBSHL-60 lymphoblast human promyeolocytic leukemia RPMI-1640, 20% FBSHT-1080 epithelial human fibrosarcoma MEM, 10% HI FBS and NEAAHT-29 epithelial human colon adenocarcinoma McCoy's 5A, 10% FBSHUVEC endothelial human umbilical cord F-12K, 10% FBS and heparinat 100 ug mlI-10 epithelial mouse testicular tumor F-10, 15% horse serum and 2.5% FBSIM-9 lymphoblast human marrow from myeloma patient RPMI-1640, 10% FBSJEG-2 epithelial human choriocarcinoma MEM, 10% FBSJensen fibroblast rat sarcoma McCoy's 5A, 5% FBSJurkat lyphoblast human lymphoma RPMI-1640, 10% FBSK-562 lymphoblast human myelogenous leukemia RPMI-1640, 10% FBSKB epithelial human oral carcinoma MEM, 10% FBS and NEAAKG-1 myeloblast human marrow from erythroleukemia patient IMDM, 20% FBSL2 epithelial rat lung F-12K, 10%FBSL6 rat skeletal muscle myoblasts DMEM, 10% FBSLLC-WRC 256 epithelial rat carcinoma Medium 199, 5% horse serumMcCoy fibroblast mouse unknown MEM, 10% FBSMCF7 epithelial human breast adenocarcinoma MEM, 10% FBS NEAA, 10ug/ml insulinWEHI-3b macrophage-like mouse myelomonocyte leukemia DMEM, 10% FBSWI-38 epithelial human embryonic lung BME, 10% FBSWISH epithelial human amnion BME, 10% FBSWS1 human embryonic skin MEM, 10% FBS and NEAAXC epithelial rat sarcoma MEM, 10% FBS and NEAAY-1 epithelial mouse tumor of adrenal F-10, 15% horse serum and 2.5% FBS
